Anti-SRCAP monoclonal antibody

Pre-made anti-SRCAP monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SRCAP/SRCAP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1818-Ab-1/ GM-Tg-hg-IP1818-Ab-2Anti-Human SRCAP monoclonal antibodyHuman
GM-Tg-rg-IP1818-Ab-1/ GM-Tg-rg-IP1818-Ab-2Anti-Rat SRCAP monoclonal antibodyRat
GM-Tg-mg-IP1818-Ab-1/ GM-Tg-mg-IP1818-Ab-2Anti-Mouse SRCAP monoclonal antibodyMouse
GM-Tg-cynog-IP1818-Ab-1/ GM-Tg-cynog-IP1818-Ab-2Anti-Cynomolgus/ Rhesus macaque SRCAP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1818-Ab-1/ GM-Tg-felg-IP1818-Ab-2Anti-Feline SRCAP monoclonal antibodyFeline
GM-Tg-cang-IP1818-Ab-1/ GM-Tg-cang-IP1818-Ab-2Anti-Canine SRCAP monoclonal antibodyCanine
GM-Tg-bovg-IP1818-Ab-1/ GM-Tg-bovg-IP1818-Ab-2Anti-Bovine SRCAP monoclonal antibodyBovine
GM-Tg-equg-IP1818-Ab-1/ GM-Tg-equg-IP1818-Ab-2Anti-Equine SRCAP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1818-Ab-1/ GM-Tg-hg-IP1818-Ab-2; GM-Tg-rg-IP1818-Ab-1/ GM-Tg-rg-IP1818-Ab-2;
GM-Tg-mg-IP1818-Ab-1/ GM-Tg-mg-IP1818-Ab-2; GM-Tg-cynog-IP1818-Ab-1/ GM-Tg-cynog-IP1818-Ab-2;
GM-Tg-felg-IP1818-Ab-1/ GM-Tg-felg-IP1818-Ab-2; GM-Tg-cang-IP1818-Ab-1/ GM-Tg-cang-IP1818-Ab-2;
GM-Tg-bovg-IP1818-Ab-1/ GM-Tg-bovg-IP1818-Ab-2; GM-Tg-equg-IP1818-Ab-1/ GM-Tg-equg-IP1818-Ab-2
Products NameAnti-SRCAP monoclonal antibody
Formatmab
Target NameSRCAP
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SRCAP monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1818-Ag-1Recombinant multi-species SRCAP/ DOMO1/ EAF1 protein


    Target information

    Target IDGM-IP1818
    Target NameSRCAP
    Gene ID10847,100043597,361652,712944,479773,101084157,100063654
    Gene Symbol and SynonymsB930091H02Rik,D030022P06Rik,DEHMBA,DOMO1,EAF1,F630004O05Rik,FLHS,RGD1565642,SRCAP,SWR1
    Uniprot AccessionQ6ZRS2
    Uniprot Entry NameSRCAP_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000080603
    Target ClassificationN/A

    The target: SRCAP, gene name: SRCAP, also named as DOMO1, EAF1, FLHS, SWR1. This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.